Profiles of professional liability in heparin prophylaxis of pulmonary thromboembolism;Management e qualità Profili di colpa professionale nella profilassi eparinica della tromboembolia polmonare

Italian Heart Journal, Supplementi

Volumn 4, Issue 3, 2002, Pages 217-225

  Montisci, Massimo ^a   Snenghi, Rossella ^a   Pasquali, Alessandro ^b   Prandoni, Paolo ^c   Ferrara, Santo Davide ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF MACERATA   (Italy)

^c UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

Author keywords

Heparin; Thromboembolism; Thrombosis

Indexed keywords

ANTICOAGULANT AGENT; FIBRINOLYTIC AGENT; HEPARIN;

CLINICAL PRACTICE; HEALTH CARE QUALITY; HUMAN; ITALY; LUNG EMBOLISM; MALPRACTICE; PREMEDICATION; REVIEW; STANDARD; VEIN THROMBOSIS;

ANTICOAGULANTS; FIBRINOLYTIC AGENTS; HEPARIN; HUMANS; ITALY; MALPRACTICE; PHYSICIAN'S PRACTICE PATTERNS; PREMEDICATION; PULMONARY EMBOLISM; QUALITY OF HEALTH CARE; VENOUS THROMBOSIS;

EID: 84949126901     PISSN: 15903796     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Silverstein MD, Heit JA, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year popula-tion-based study. Arch Intern Med 1998; 158: 585-93.
2. Dalen JE. Pulmonary embolism: what have we learned since Virchow?: treatment and prevention. Chest 2002; 122: 1801-17.
3. Prandoni P, Ten Cate JW. Epidemiology, risk factors, and natural history of venous thromboembolism. In: Oudkerk M, van Beek EJR, Ten Cate JW, eds. Pulmonary embolism. Berlin: Blackwell Science, 1999: 2-33.
4. Fink S, Chaudhuri TK, Davis HH. Pulmonary embolism and malpractice claims. South Med J 1998; 91: 1149-52.
5. Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 1999; 353: 1386-9.
6. Daisley H. Pulmonary embolism as a cause of death. West Indian Med J 1990; 39: 86-90.
7. Prandoni P. Terapia e prevenzione della malattia tromboem-bolica venosa. Padova: Piccin, 2000.
8. Kaboli P, Henderson MC, White RH. DVT prophylaxis and anticoagulation in the surgical patient. Med Clin North Am 2003; 87: 77-110.
9. Geerts WH, Heit JA, Clagett GP, et al. Prevention of venous thromboembolism. Chest 2001; 119 (Suppl): 132S-175S.
10. Kakkar VV, Boeckl O, Boneu B, et al. Efficacy and safety of a low-molecular-weight heparin and standard unfractionated heparin for prophylaxis of postoperative venous thromboembolism: European multicenter trial. World J Surg 1997;21:2-8.
11. Bergqvist D, Burmark US, Flordal PA, et al. Low molecular weight heparin started before surgery as prophylaxis against deep vein thrombosis: 2500 versus 5000 Xal units in 2070 patients. Br J Surg 1995; 82: 496-501.
12. Paiement GD, Mendelsohn C. The risk of venous thromboembolism in the orthopedic patient: epidemiological and physiological data. Orthopedics 1997; 20 (Suppl): 7-9.
13. Demers C, Marcoux S, Ginsberg JS, Laroche F, Cloutier R, Poulin J. Incidence of venographically proved deep vein thrombosis after knee arthroscopy. Arch Intern Med 1998; 158: 47-50.
14. Dahl OE, Bergqvist D. Current controversies in deep vein thrombosis prophylaxis after orthopaedic surgery. Curr Opin Pulm Med 2002; 8: 394-7.
15. Gent M, Hirsh J, Ginsberg JS, et al. Low-molecular-weight heparinoid orgaran is more effective than aspirin in the prevention of venous thromboembolism after surgery for hip fracture. Circulation 1996; 93: 80-4.
16. EskanderMB, Limb D.Stone MH, et al. Sequential mechanical and pharmacological thromboprophylaxis in the surgery of hip fractures. A pilot study. Int Orthop 1997; 21: 259-61.
17. Dahl OE, Andreassen G, Aspelin T, et al. Prolonged thromboprophylaxis following hip replacement surgery - results of a double-blind, prospective, randomised, placebo-controlled study with dalteparin (Fragmin). Thromb Haemost 1997;77:26-31.
18. Wysowski DK, Talarico L, Bacsanyi J, Botstein P. Spinal and epidural haematoma and low-molecular-weight heparin. N Engl J Med 1998; 338: 1774-5.
19. Nurmohamed MT, van Riel AM, Henkens CM, et al. Low molecular weight heparin and compression stockings in the prevention of venous thromboembolism in neurosurgery. Thromb Haemost 1996; 75: 233-8.
20. Agnelli G, Piovella F, Buoncristiani P, et al. Enoxaparin plus compression stockings compared with compression stockings alone in the prevention of venous thromboembolism after elective neurosurgery. N Engl J Med 1998; 339: 80-5.
21. Green D. Prophylaxis of thromboembolism in spinal cord injury patients. Chest 1994; 102: 649-51.
22. Kim J, Gearhart MM, Zurick A, Zuccarello M, James L, Luchette FA. Preliminary report on the safety of heparin for deep venous thrombosis prophylaxis after severe head injury. J Trauma 2002; 53: 38-42.
23. Rogers FB, Cipolle MD, Velmahos G, Rozycki G, Luchette FA. Practice management guidelines for the prevention of venous thromboembolism in trauma patients: the EAST practice management guidelines work group. J Trauma 2002; 53: 142-64.
24. Turpie AG. Thrombosis prophylaxis in the acutely ill medical patient: insights from the prophylaxis in MEDical patients with ENOXaparin (MEDENOX) trial. Am J CardioI 2000; 86 (12B): 48M-52M.
25. Introna F. Metodologia medico-legale nella valutazione della responsabilità medica per colpa. Rivista Italiana di Medicina Legale 1996; 17: 1295-350.
26. Montisci M, Ruscazio M, Snenghi R, et al. Aspetti medicolegali della dimissione precoce nell'infarto miocardico acuto e nel dolore toracico. Ital Heart J Suppl 2001; 2: 634-9.
27. Stella F. Leggi scientifiche e spiegazione causale in diritto penale. Milano: Giuffrè, 1990: 125.
28. Barni M. Il rapporto di causalità materiale in medicina legale. Milano: Giuffrè, 1995: 51-79.
29. Trenta G, Righi E. La probabilità di causa e la medicina legale. In: Barni M, ed. Consulenza medico-legale e responsabilità professionale medica. Impegno etico-scientifico in divenire. Milano: Giuffrè, 2002: 129-31.
30. Stella F. In tema di causalità e di "causalità medica". Rivista Italiana di Medicina Legale 2001; 23: 525-48.
31. Fiori A. Il nesso causale e la medicina legale: un chiarimento indifferibile. Rivista Italiana di Medicina Legale 2002; 24: 247-65.
32. Barni M. Evidence-based medicine e medicina legale. Rivista Italiana di Medicina Legale 1998; 20: 3-10.
33. Benciolini P. . a'scopo medico legale. Rivista Italiana di Medicina Legale 1991; 13: 689-99.
34. Bartone N. La colpa del medico nel trattamento a mezzo farmaci. Problematica e giurisprudenza della Cassazione. Giustizia Penale 1986; 234-55.